Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px

News > Ireland & UK

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 2627 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Sanofi S.A.. (9/16/16). "Press Release: Treatment Effects Maintained Over Six Years in Patients with Relapsing Remitting Multiple Sclerosis who Received Sanofi Genzyme’s Lemtrada (alemtuzumab) in Clinical Trials". Paris. 2016-09-16
Abingworth LLP. (9/16/16). "Press Release: GammaDelta Therapeutics Raises Seed Funding from Abingworth". 2016-09-16
Merck KGaA. (9/16/16). "Press Release: Merck Presents New Data Examining Durable Efficacy with Investigational Cladribine Tablets in Multiple Sclerosis". Darmstadt. 2016-09-16
PsiOxus Therapeutics Ltd.. (9/16/16). "Press Release: PsiOxus Therapeutics Announce Executive Team Reorganization with Two New C Level Appointments in the US". Oxford. 2016-09-16
Proteome Sciences plc. (9/15/16). "Press Release: Interim Results. Proteome Sciences Today Releases Its Unaudited Interim Results for the Six Months Ended 30th June 2016". 2016-09-15
Loughborough University. (9/15/16). "Press Release: Loughborough Researchers Develop Simple Saliva Test to Diagnose Asthma". 2016-09-15
Merck KGaA. (9/12/16). "Press Release: Merck Presents New Data on the Safety and Durable Efficacy of Cladribine Tablets and Advantages of Early Treatment with Rebif at the 2016 ECTRIMS Congress". Darmstadt. 2016-09-12
Microsaic Systems plc. (9/12/16). "Press Release: Result of General Meeting, Completion of Placing and Total Voting Rights". 2016-09-12
Kymab Ltd.. (9/9/16). "Press Release: Kymab's Early Steps Towards HIV Vaccine". Cambridge. 2016-09-09
Vivasure Medical Ltd.. (9/8/16). "Press Release: Vivasure Medical Announces €16.2M ($18.3M) in Financing to Advance Commercialization of Closure Device in European Union and United States". Galway. 2016-09-08
Adaptimmune Therapeutics plc. (9/8/16). "Press Release: Adaptimmune to Participate in Two Upcoming Investor Conferences". Philadeliphia, PA & Oxford. 2016-09-08
Horizon Discovery Group plc. (9/6/16). "Press Release: Horizon Discovery and Fulcrum Therapeutics Form Collaboration for Novel CRISPR-Based Target Discovery in Genetic Diseases". Cambridge. 2016-09-06
Peak Scientific Instruments Ltd.. (9/1/16). "Press Release: Peak Introduces Solaris Nitrogen – Gas Solution for ELSD & Compact MS Applications". 2016-09-01
MRC Technology. (9/1/16). "Press Release: New Collaboration to Explore Novel Treatments for Respiratory Diseases". London. 2016-09-01
Oxford Immunotec Global plc. (9/1/16). "Press Release: Oxford Immunotec Announces Favorable Recommendation by the Magistrate Judge in Patent Infringement Litigation". Oxford & Marlborough, MA. 2016-09-01
Horizon Discovery Group plc. (9/1/16). "Press Release: Horizon Discovery Group and Ventana Medical Systems Sign Co-development Agreement for Reference Standards". Cambridge. 2016-09-01
Phagenesis Ltd.. (9/1/16). "Press Release: The Staged Acquisition of Phagenesis by Nestlé Health Science Will Benefit Patients with Dysphagia". Manchester. 2016-09-01
Roche. (9/1/16). "Press Release: Phase III Efficacy Results of Investigational Medicine Ocrevus (ocrelizumab) Reinforced by Exploratory Analyses in Two Forms of Multiple Sclerosis". Basel. 2016-09-01
Microsaic Systems plc. (8/26/16). "Press Release: Interim Results and Management Update for the Six Months Ended 30 June 2016". 2016-08-26
Microsaic Systems plc. (8/26/16). "Press Release: Result of Placing". 2016-08-26
Microsaic Systems plc. (8/26/16). "Press Release: Proposed Placing of up to 108,000,000 New Ordinary Shares at 5 Pence per Share and Notice of General Meeting". 2016-08-26
SpectralWorks Ltd.. (8/26/16). "Press Release: SpectralWorks Releases AnalyzerPro Version 5.3". 2016-08-26
Cyprotex plc. (8/25/16). "Press Release: Cyprotex Install Two AB Sciex TripleTOF 6600 Mass Spectrometer Systems". 2016-08-25
AstraZeneca plc. (8/24/16). "Press Release: AstraZeneca to Sell Small Molecule Antibiotics Business to Pfizer. Value-creating Divestment Supports AstraZeneca’s Focus on Three Main Therapy Areas". 2016-08-24
Oxford Immunotec Global plc. (8/24/16). "Press Release: Oxford Immunotec to Present at the Baird 2016 Global Healthcare Conference". Oxford & Marlborough, MA. 2016-08-24
GE Healthcare. (8/23/16). "Press Release: GE Healthcare Expands Cell Therapy Portfolio with License of Stemcell Technologies’ T-Cell Reagents". Chalfont St. Giles. 2016-08-23
AstraZeneca plc. (8/22/16). "Press Release: AstraZeneca and Lilly Receive FDA Fast Track Designation for AZD3293, an Investigational Treatment for Early Alzheimer’s Disease". 2016-08-22
Consilium Strategic Communications Ltd.. (8/22/16). "Press Release: Consilium Strategic Communications Advises Cambridge Innovation Capital on Its £75m Fundraise". 2016-08-22
Bayer AG. (8/19/16). "Press Release: Bayer and CRISPR Therapeutics Joint Venture, Named Casebia Therapeutics, Establishes Operations in Cambridge, MA". Leverkusen & Basel. 2016-08-19
Cambridge Innovation Capital plc. (8/19/16). "Press Release: Cambridge Innovation Capital Raises £75 Million via Private Financing". 2016-08-19
Excivion Ltd.. (8/18/16). "Press Release: Excivion Ltd. Announces Collaboration with Xenetic Biosciences, US, to Develop a Novel Combined Zika and Dengue Vaccine". Cambridge. 2016-08-18
Indivior plc. (8/17/16). "Press Release: Indivior Announces Positive Top-line Phase 3 Pivotal Study Results for RBP-6000 Buprenorphine Monthly Depot for the Treatment of Opioid Use Disorder". Slough, UK. 2016-08-17
GlaxoSmithKline plc. (8/16/16). "Press Release: ViiV Healthcare Launches Phase III Programme Evaluating a Two-drug Regimen Combining Dolutegravir and Lamivudine for HIV-1 Treatment". 2016-08-16
Peak Scientific Instruments Ltd.. (8/10/16). "Press Release: Peak Scientific Introduces Innovative Gas Subscription Service. New FlexFlow Service Offers the Benefits of a Generator with a Monthly Rental Cost". 2016-08-10
AstraZeneca plc. (8/9/16). "Press Release: AstraZeneca Provides Update on Phase III Trial of Selumetinib in Non-small Cell Lung Cancer". 2016-08-09
Adaptimmune Therapeutics plc. (8/8/16). "Press Release: Adaptimmune Reports Second Quarter 2016 Financial Results". Philadeliphia, PA & Oxford. 2016-08-08
Chronos Therapeutics Ltd.. (8/4/16). "Press Release: Chronos Therapeutics Strengthens Management Team with Appointment of Dr Fraser Murray and Dr Timothy Schulz-Utermoehl as Vice Presidents of Pre-Clinical Development". Oxford. 2016-08-04
Repositive. (8/4/16). "Press Release: Repositive Launches Consortium with AstraZeneca to Improve Oncology Research". Cambridge. 2016-08-04
AMETEK, Inc.. (8/4/16). "Press Release: AMETEK Completes Two Acquisitions. Nu Instruments Adds to Position in High-End Elemental Analysis – HS Foils Brings Unique Technology to Materials Analysis Business". Berwyn, PA. 2016-08-04
Adaptimmune Therapeutics plc. (8/3/16). "Press Release: Adaptimmune Announces Partial Clinical Hold of Planned Pivotal Study of NY-ESO SPEAR T-cell Therapy in Myxoid Round Cell Liposarcoma". Philadeliphia, PA & Oxford. 2016-08-03
Oxford Immunotec Global plc. (8/2/16). "Press Release: Oxford Immunotec Reports Second Quarter 2016 Financial Results". Oxford & Marlborough, MA. 2016-08-02
GlaxoSmithKline plc. (8/1/16). "Press Release: GSK and Verily to Establish Galvani Bioelectronics – a New Company Dedicated to the Development of Bioelectronic Medicines". 2016-08-01
Cosmo Pharmaceuticals N.V.. (7/29/16). "Press Release: Cosmo Reports Growth in Product Revenues and Progress in Late Stage Product and Corporate Development". Dublin. 2016-07-29
Adaptimmune Therapeutics plc. (7/28/16). "Press Release: Adaptimmune Receives Access to Priority Medicines (PRIME) Regulatory Support for its SPEAR® T-cell Therapy Targeting NY-ESO for Treatment of Soft Tissue Sarcoma". Philadeliphia, PA & Oxford. 2016-07-28
Selvita S.A.. (7/28/16). "Press Release: Epidarex Capital Creates Nodthera Limited". Edinburgh. 2016-07-28
Proteome Sciences plc. (7/28/16). "Press Release: Trading Update and Notice of Results". 2016-07-28
GlaxoSmithKline plc. (7/27/16). "Press Release: GSK Announces Significant New Investment in UK Manufacturing Network. Total of £275 million to Be Invested". 2016-07-27
GlaxoSmithKline plc. (7/27/16). "Press Release: GSK In-licenses anti-IL-33R Monoclonal Antibody for Severe Asthma from Janssen". London. 2016-07-27
GlaxoSmithKline plc. (7/27/16). "Press Release: Results Announcement for the Second Quarter 2016 and Half-yearly Financial Report for the Half-year 2016". 2016-07-27
Adaptimmune Therapeutics plc. (7/26/16). "Press Release: Adaptimmune Receives Orphan Drug Designation in the European Union for its NY-ESO SPEAR T-cell Therapy for Treatment of Soft Tissue Sarcoma". Philadeliphia, PA & Oxford. 2016-07-26
John Wiley & Sons. (7/26/16). "Press Release: Wiley Announces Launch of Wiley Spectra Lab, Giving Researchers Access to Largest Collection of Reference Spectra in the World". 2016-07-26
Horizon Discovery Group plc. (7/20/16). "Press Release: Horizon Discovery Takes Exclusive License to a Range of Melanoma Patient-Derived Xenograft Models". Cambridge & Philadelphia, PA. 2016-07-20
Chronos Therapeutics Ltd.. (7/20/16). "Press Release: Chronos Therapeutics Acquires Pre-clinical Programmes from Shire. Expands Pipeline With Novel CNS Assets in a Transformative Deal". Oxford. 2016-07-20
Precision Ocular Ltd.. (7/19/16). "Press Release: Precision Ocular Ltd Completes £15.5 Million Series A Financing. V-Bio Ventures Joins Investment Syndicate". 2016-07-19
AstraZeneca plc. (7/19/16). "Press Release: AstraZeneca Receives Approval in the EU for Qtern (saxagliptin and dapagliflozin) for Treatment of Type 2 Diabetes". 2016-07-19
Evonetix Ltd.. (7/19/16). "Press Release: One in a Billion. Cambridge Consultants Spin-out Evonetix Poised to Transform Synthetic Biology Industry". 2016-07-19
Bicycle Therapeutics Ltd.. (7/18/16). "Press Release: Bicycle Therapeutics Appoints Stephen J. Hoffman, M.D., Ph.D., as Board Chairman". Cambridge, MA & Cambridge. 2016-07-18
GlaxoSmithKline plc. (7/18/16). "Press Release: ARIA Study Shows Superior Efficacy of Triumeq for Treatment-naïve Women Living with HIV". London & Durban. 2016-07-18
AstraZeneca plc. (7/18/16). "Press Release: Tagrisso Met Primary Endpoint in Phase III 2nd-line Lung Cancer Trial". 2016-07-18
MRC Technology. (7/15/16). "Press Release: MRC Technology Monetises Royalties on Cancer Drug Keytruda (pembrolizumab) to Expand Medical Research Activities, with a Fund Managed by DRI Capital". 2016-07-15
F-Star Biotechnology Ltd.. (7/14/16). "Press Release: F-Star Announces Funding and Collaboration Extension with New Christian Doppler Lab for Innovative Immunotherapeutics". Cambridge. 2016-07-14
Avacta Group plc. (7/14/16). "Press Release: Avacta and Glythera Announce Collaboration to Develop Novel, Potentially Highly Potent, Drug Class". 2016-07-14
e-Therapeutics plc. (7/13/16). "Press Release: Board Update". Oxford. 2016-07-13
e-Therapeutics plc. (7/13/16). "Press Release: Directorate Change". Oxford. 2016-07-13
Cell Medica Ltd.. (7/12/16). "Press Release: Cell Medica Acquires Delenex Therapeutics". London. 2016-07-12
F2G Ltd.. (7/11/16). "Press Release: F2G Ltd Announces the Appointment of Ralf Schmid to the Position of Chief Financial Officer". Manchester. 2016-07-11
University of Bath. (7/11/16). "Press Release: Spying on Chemistry in Real-time". 2016-07-11
Ablatus Therapeutics Ltd.. (7/8/16). "Press Release: Ablatus Therapeutics Founded to Develop and Commercialise Pioneering Cancer Treatment. Spin Out Company Raises £500k Seed Funding". Cambridge & Norwich. 2016-07-08
Scientific Laboratory Supplies Ltd. (SLS). (7/6/16). "Press Release: Analab Ltd Acquired by Scientific Laboratory Supplies in Market Growth Plan". 2016-07-06
Scientific Laboratory Supplies Ltd. (SLS). (7/5/16). "Press Release: Dominique Dutscher (DD) and Scientific Laboratory Supplies Ltd (SLS) Join Forces to Better Serve Their Customers across Europe". Brumath & Nottingham. 2016-07-05
AstraZeneca plc. (7/1/16). "Press Release: AstraZeneca Enters Licensing Agreements with LEO Pharma in Skin Diseases". 2016-07-01
GlaxoSmithKline plc. (6/30/16). "Press Release: GSK Announces Start of Phase I Oncology Study with Its ICOS Agonist Antibody". London. 2016-06-30
AB Sciex (d/b/a Sciex). (6/28/16). "Press Release: The University of Manchester and Sciex Opened the £18m Stoller Biomarker Discovery Centre on June 14th". Framingham, MA & Manchester. 2016-06-28
AstraZeneca plc. (6/28/16). "Press Release: New Antibiotic Zavicefta Approved in the European Union for Patients with Serious Bacterial Infections". 2016-06-28
Bruker Corporation. (6/28/16). "Press Release: Bruker Announces More Comprehensive and Efficient NMR Profiling Module for Detailed Lipoprotein Subclass Analysis in Cardiovascular Disease Research". Dublin. 2016-06-28
Owlstone Medical. (6/28/16). "Press Release: Owlstone Medical Closes $7M (£4.9M) Investment to Commercialize Disease Breathalyzer". Cambridge. 2016-06-28
Storm Therapeutics Ltd.. (6/28/16). "Press Release: Storm Therapeutics Raises £12 Million Series A Funding to Develop Novel Cancer Therapeutics". 2016-06-28
Oxford Immunotec Global plc. (6/23/16). "Press Release: Oxford Immunotec Enters into Definitive Agreement to Acquire Imugen". Oxford & Marlborough, MA. 2016-06-23
Thermo Fisher Scientific Inc.. (6/23/16). "Press Release: Thermo Fisher Scientific and NIBRT Announce Scientific Collaboration for Biopharmaceutical Characterisation". Waltham, MA & Dublin. 2016-06-23
Adaptimmune Therapeutics plc. (6/21/16). "Press Release: Adaptimmune Announces Commercial Development and Supply Agreement for Thermo Fisher Scientific’s Dynabeads CD3/CD28 Cell Therapy System". Philadeliphia, PA & Oxford. 2016-06-21
Mironid Ltd.. (6/20/16). "Press Release: Mironid Announces Closing of £4.3 million ($6.2 million) Series A Financing". Glasgow. 2016-06-20
F2G Ltd.. (6/20/16). "Press Release: F2G Ltd Announces $60 Million Financing to Progress Development of Novel Antifungal Agents". Manchester. 2016-06-20
MRC Technology. (6/15/16). "Press Release: MRC Technology and AstraZeneca Call for Epigenetic Targets in Respiratory Disease". London. 2016-06-15
Cosmo Pharmaceuticals N.V.. (6/15/16). "Press Release: Cosmo Announces European Approval of Eleview". Dublin. 2016-06-15
GlaxoSmithKline plc. (6/14/16). "Press Release: Executive Director Change". London. 2016-06-14
Eurofins Scientific. (6/13/16). "Press Release: Eurofins Lancaster Laboratories Announces Major Expansion Plans to Enhance Its Laboratory Services Footprint and Create New Jobs in Ireland". 2016-06-13
Ziarco Pharma Ltd.. (6/13/16). "Press Release: Ziarco Reports Positive Phase 2a Study Results with ZPL-389 in Moderate to Severe Atopic Dermatitis Patients". Discovery Park, Sandwich. 2016-06-13
AB Sciex (d/b/a Sciex). (6/13/16). "Press Release: The University of Manchester and Sciex to Open the £18m Stoller Biomarker Discovery Centre on June 14th". Framingham, MA & Manchester. 2016-06-13
GlaxoSmithKline plc. (6/10/16). "Press Release: ViiV Healthcare Announces FDA Approval to Lower the Weight Limit for Dolutegravir in Children and Adolescents Living with HIV". London. 2016-06-10
AstraZeneca plc. (6/9/16). "Press Release: AstraZeneca Enters Commercialisation Agreement with Aspen for Anaesthetic Medicines Portfolio". 2016-06-09
Axol Bioscience Ltd.. (6/9/16). "Press Release: MESO-BRAIN Initiative Receives €3.3 Million to Replicate Brain’s Neural Networks Through 3D Nanoprinting". Birmingham, Cambridge, et al.. 2016-06-09
Consilium Strategic Communications Ltd.. (6/7/16). "Press Release: Melissa Gardiner Joins Consilium Strategic Communications from AstraZeneca". London. 2016-06-07
Cobra Biologics Ltd.. (6/7/16). "Press Release: Cobra Biologics and Touchlight Collaborate on Production of Next Generation DNA Constructs". Keele & London. 2016-06-07
F-Star Biotechnology Ltd.. (6/7/16). "Press Release: F-Star Announces an Agreement with CMC Biologics for Manufacture of mAb2 Bispecific Antibodies". Cambridge. 2016-06-07
Horizon Discovery Group plc. (6/7/16). "Press Release: Horizon Discovery Signs License Agreement with ProteoNic B.V. for the Provision of Expression Vectors Alongside Horizon Bioproduction Cell Lines". Cambridge. 2016-06-07
Immunocore Ltd.. (6/6/16). "Press Release: Immunocore Presents Positive IMCgp100 Phase I Data at the 2016 ASCO Annual Meeting". Oxford. 2016-06-06
PureTech Health plc. (6/6/16). "Press Release: PureTech's Vedanta Biosciences Raises $50 Million to Further Advance Microbiome Platform and Pipeline". 2016-06-06
Cosmo Pharmaceuticals N.V.. (6/6/16). "Press Release: Cosmo Announces Successful Outcome of Phase III Clinical Trial for Rifamycin SV MMX". Dublin. 2016-06-06
Shire plc. (6/3/16). "Press Release: Shire to Participate at Two Upcoming Investor Conferences". Lexington, MA. 2016-06-03
Shire plc. (6/3/16). "Press Release: Shire Completes Combination with Baxalta Creating the Global Leader in Rare Diseases and Highly Specialized Conditions". Dublin. 2016-06-03
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top